The pharmaceutical industry is preparing for ‘major disruptions’ following US President Donald Trump’s announcement on ...

South Korea-based Celltrion today announced that the European Commission (EC) has granted marketing authorization for three ...

FibroGen today announced the sale of its China subsidiary to UK pharma major AstraZeneca for around $160 million, with the ...

CSPC Megalith Biopharmaceutical has entered into a license agreement with Radiance Biopharma for the development and ...

Japanese drugmaker Chugai Pharmaceutical today announced gaining regulatory approval from the Ministry of Health, Labor and ...

Sweden’s BioArctic today revealed that the US Federal Trade Commission (FTC) has cleared the proposed deal with Bristol Myers ...

US CNS specialist Supernus Pharmaceuticals has announced that its Phase IIb study of SPN-820 in adults with ...

In a U-turn for the UK health technology assessor, the National Institute for Health and Care Excellence (NICE) has today ...

Hong Kong-based Ascletis Pharma announced today positive interim results from the first two cohorts of its randomized, double ...

New Jersey, USA-based Imunon announced new translational data from the Phase II OVATION 2 Study of IMNN-001, an ...

New research shows that 46% of generic drugs from the European Union (EU) critical list of medicines are supplied by just one provider.

The International Generic and Biosimilar Medicines Association (IGBA), in line with its goals of promoting the widest possible access to safe, effective, and quality-assured medicines and of promoting ...